Pyridoxine dependent seizures were first described by Hurst et de- carboxylase, which catalyses the conversion of glutamic acid to gamma-aminobutyric acid, an inhibitory neurotransmitter in the central nervous system. The reduced concentrations of gammaaminobutyric acid result in a lower seizure threshold.2 The typical natural history of pyridoxine dependent seizures is fits beginning within hours of birth which are difficult to control with anticonvulsant drugs but 'turn off' within minutes of the administration of parenteral pyridoxine, after which the baby is often floppy and unresponsive for a period. There may be a history of intrauterine convulsive movements. Fetal distress in labour and meconium stained Jiquor are common, and the baby may appear asphyxiated at birth. Pyridoxine in pharmacological dosage controls the seizures, but they usually recur within days of stopping pyridoxine and recurrence is often preceded by irritability. Mental development is usually impaired. We report on 4 babies with pyridoxine dependent seizures in whom the clinical presentation and subsequent course have been atypical, suggesting that the manifestations of this disorder may present a broader range than is generally thought. This has important implications for diagnosis. Although the classic picture of pyridoxine dependency described in the introduction is imprinted in the minds of doctors, the clinical picture, even in the published reports, is much broader. A review of 36 cases1-18 gives the following symptoms. The average age of onset of seizures was 4 hours, but it varied from onset at birth to onset at 3 months of age.3 Unusual fetal movements, suggesting intrauterine seizures, have been described. A seizure free period on anticonvulsant drugs without pyridoxine was unusual, but there were isolated reports of such periods lasting up to three weeks.45 Seizures normally stopped quickly after pyridoxine had been given, after an average interval of 10 minutes, but this has taken up to an hour.6 Seizures have been described as generalised, or focal becoming generalised.6-9 The interval between giving intravenous pyridoxine and normalisation of the EEG has varied from minutes1 8 to several weeks.6 Recurrence of seizures while on pyridoxine may be caused by intercurrent illnesses or growth of the child. After stopping pyridoxine, seizures recurred sooner in the neonate (1 j to 7 days) than in the older child (2 to 14 days). In one presumptive case treated incidentally with vitamins, including 5 mg pyridoxine, from day 4 for 6 days, seizures did not occur until 23 days after withdrawal of pyridoxine.9 The minimum daily requirement of pyridoxine has ranged from 2 to 200 mg. Most of the children have been mentally retarded. Children reported to be mentally normal have responded rapidly to the dose of parenteral pyridoxine-in less than 5 minutes.4-6 8 Small doses of pyridoxine taken by the mother in late pregnancy did not influence the outcome favourably in two cases,7 12 but in the third4 the infant was not mentally retarded. In one report, large doses of 110 mg a day of pyridoxine stopped the fetal movements which suggested intrauterine convulsions,7 but that child, although treated from birth, was mildly mentally retarded.
The patients described illustrate a broader range of clinical features than is commonly appreciated. The unusual features that led to diagnostic uncertainty include:
(1) Late onset of seizures (day 8 
